• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • English
  • Spanish

Genetic predisposition to bacterial infections

Inicio » Noticias UE » Sanidad » Diseases » Genetic predisposition to bacterial infections

12 de July de 2022

We know that we inherit features from our parents and genetic diseases too. European researchers now demonstrate that our DNA also predisposes us to severe bacterial infections.

Staphylococcus aureus is a pathogen that can lead to a variety of clinical manifestations. Although it typically causes common, superficial infections, some people suffer from severe, life-threatening infections. No vaccine is available, and treatment of infections can be challenging due to the emergence of drug resistant strains such as methicillin-resistant S. aureus (MRSA).

Genetic predisposition to S. aureus infections

Certain risk factors predispose to severe S. aureus infections, but collectively explain only a few cases. Therefore, scientists of the HGB-StIC project were interested in determining underlying genetic factors that could predispose otherwise healthy individuals to severe staphylococcal disease. Research was undertaken with the support of the Marie Skłodowska-Curie Actions (MSCA) programme. “Our society’s challenge of antimicrobial resistance requires an approach that innovatively fuses clinical practice and fundamental sciences,” highlights the MSCA research fellow Andras Spaan. Spaan and his team aimed to dissect the human genetic basis of severe bacterial infections and unravel host-pathogen interactions at the molecular, cellular, tissue and whole-organism levels. For this purpose, they integrated cutting-edge human genetic strategies with in-depth functional studies.

Antimicrobial resistance in the EU: infections with foodborne bacteria becoming harder to treat

 

OTULIN: an enzyme with a role in immunity

Spaan screened for genetic homogeneity in a cohort of patients with unexplained life-threatening staphylococcal disease. The team discovered a genome-wide enrichment for heterozygous OTULIN variants in patients with severe staphylococcal disease. OTULIN is an enzyme encoded by a gene located on chromosome 5p. OTULIN is a negative regulator of the NF-κB-signalling pathway which acts on innate and adaptive immune responses, mediating inflammatory responses. Biallelic OTULIN mutations cause an early onset autoinflammatory condition. The patients carrying heterozygous OTULIN mutations described by Spaan suffered from life-threatening skin or pulmonary necrosis. Their disease was typically triggered by S. aureus infections and occurred from adolescence onwards.

OTULIN as a novel determinant of staphylococcal disease

The loss of one functional copy of the OTULIN gene leads to a condition known as haploinsufficiency where the amount of enzyme produced by the functional gene is not enough. The study led by Spaan suggests that people with a genetic condition known as 5p- (or Cri-du-chat) syndrome may be at a similar risk. The researchers found that blood leukocyte subsets in OTULIN-haploinsufficient patients were unaffected. Surprisingly, they discovered that OTULIN haploinsufficiency disrupts cell-intrinsic immunity of non-hematopoietic cells against the staphylococcal virulence factor alpha-toxin. Not all individuals with OTULIN haploinsufficiency will get severe infections. These people may have high levels of naturally elicited alpha-toxin-neutralising antibodies and thus be protected by a compensatory mechanism. “Our growing global failure to treat infections could effectively mean the end of modern medicine as we know it. Genetic studies in patients who suffer from severe infectious diseases will provide a better understanding of this predisposition on a molecular level and help us to identify innovative and personalised strategies to treat infectious diseases,” concludes Spaan.

Source

European Commission — CORDIS

Publicaciones relacionadas:

COVID-19: ECDC updates case definition for EU surveillance The European Commission will address the issue of Coronavirus at its meeting on 5th March Statement by the President of the ECB about Covid-19 COVID-19: UN releases US$15 million to help vulnerable countries to combat coronavirus NOW: Press conference about Coronavirus

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas


COVID-19: ECDC updates case definition for EU surveillance


The European Commission will address the issue of Coronavirus at its meeting on 5th March


Statement by the President of the ECB about Covid-19


COVID-19: UN releases US$15 million to help vulnerable countries to combat coronavirus


NOW: Press conference about Coronavirus

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información